1. Home
  2. MREO vs MUA Comparison

MREO vs MUA Comparison

Compare MREO & MUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • MUA
  • Stock Information
  • Founded
  • MREO 2015
  • MUA 1993
  • Country
  • MREO United Kingdom
  • MUA United States
  • Employees
  • MREO N/A
  • MUA N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • MUA Investment Bankers/Brokers/Service
  • Sector
  • MREO Health Care
  • MUA Finance
  • Exchange
  • MREO Nasdaq
  • MUA Nasdaq
  • Market Cap
  • MREO 438.8M
  • MUA 405.2M
  • IPO Year
  • MREO N/A
  • MUA N/A
  • Fundamental
  • Price
  • MREO $1.76
  • MUA $10.23
  • Analyst Decision
  • MREO Strong Buy
  • MUA
  • Analyst Count
  • MREO 5
  • MUA 0
  • Target Price
  • MREO $7.20
  • MUA N/A
  • AVG Volume (30 Days)
  • MREO 4.4M
  • MUA 92.6K
  • Earning Date
  • MREO 08-12-2025
  • MUA 01-01-0001
  • Dividend Yield
  • MREO N/A
  • MUA 4.84%
  • EPS Growth
  • MREO N/A
  • MUA N/A
  • EPS
  • MREO N/A
  • MUA N/A
  • Revenue
  • MREO N/A
  • MUA N/A
  • Revenue This Year
  • MREO N/A
  • MUA N/A
  • Revenue Next Year
  • MREO $51.92
  • MUA N/A
  • P/E Ratio
  • MREO N/A
  • MUA N/A
  • Revenue Growth
  • MREO N/A
  • MUA N/A
  • 52 Week Low
  • MREO $1.57
  • MUA $8.61
  • 52 Week High
  • MREO $5.02
  • MUA $11.43
  • Technical
  • Relative Strength Index (RSI)
  • MREO 35.35
  • MUA 45.53
  • Support Level
  • MREO $1.65
  • MUA $10.02
  • Resistance Level
  • MREO $1.89
  • MUA $10.32
  • Average True Range (ATR)
  • MREO 0.15
  • MUA 0.13
  • MACD
  • MREO -0.03
  • MUA -0.02
  • Stochastic Oscillator
  • MREO 12.84
  • MUA 37.27

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About MUA Blackrock MuniAssets Fund Inc

Blackrock Muniassets Fund Inc is a closed-end fund. Its objective is to provide high current income exempt from U.S. federal income taxes by investing in a portfolio of medium- to lower-grade or unrated municipal obligations. The Fund invests more of its total assets in municipal bonds.

Share on Social Networks: